Nirupama Ramadas; Erica Sparkenbaugh/LinkedIn
Nov 3, 2025, 04:56
Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
RPTH Journal shared on LinkedIn:
”Sickle cell disease (SCD) is more than a hemoglobinopathy, it’s a chronic thrombo-inflammatory disorder.
This review from Nirupama Ramadas and Erica Sparkenbaugh explores how hemolysis, endothelial activation, and cellular aggregates drive thrombosis, organ injury, and inflammation, and what that means for future therapies.
Read more.”
Read the full article in RPTH.
Article: Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis
Authors: Nirupama Ramadas, Erica Sparkenbaugh
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 8, 2026, 13:58Alan Nurden: A “Gold Medal” Study on Silk Fibroin 3D Models for Bone Marrow Fibrosis
-
Feb 8, 2026, 13:45Shinya Goto։ New Lancet Meta-Analysis on Statin-Related Adverse Effects
-
Feb 8, 2026, 13:29Andrea Marshall: Highlighting the Impact of PBM Conference 2026 on Patient-Centred Blood Care
-
Feb 8, 2026, 13:12OncoDaily’s Managing Editor Elen Baloyan Releases Her First Mini-EP
-
Feb 8, 2026, 12:57Shiny K. Kajal: A Hidden Cause of Persistent Mild Anemia
-
Feb 8, 2026, 12:54Gokul Patil Receives AHA Funding to Investigate Thrombo-Inflammatory Mechanisms Underlying Long COVID
-
Feb 7, 2026, 17:00Heghine Khachatryan: Despite Progress, Many People with Hemophilia Remain Undiagnosed Worldwide
-
Feb 7, 2026, 16:53Priyansh Shah and Romit Bhattacharya Address Patients’ Concerns on GLP-1
-
Feb 7, 2026, 16:43Wolfgang Miesbach: Comparing Clinician-Assessed and Patient-Reported Bleeding Scores and Quality of Life